| Vol. 23.25 – 18 July, 2022 |
| |
|
|
| Transplantation of stem cell-derived β cells with ZnT8 loss of function into mice with pre-existing diabetes significantly improved glycemia restoration and glucose tolerance. [Nature Communications] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| The authors demonstrated that Sema3F-transduced HSCs stimulate oligodendrocyte progenitor cell (OPC) migration in a neuropilin 2-dependent fashion, which was conserved in middle-aged OPCs. [EMBO Molecular Medicine] |
|
|
|
| Scientists used a transcription factor EB nuclear translocation-mediated mesenchymal stem cells co-culture approach to reconstitute autophagy and lysosomal biogenesis, and reduced spinocerebellar ataxia type 3-like behaviors in induced pluripotent stem cells-derived neuron cells models. [Cell Death & Disease] |
|
|
|
| Activated CD8+ T cells and interferon-γ were found to stimulate adipogenesis of bone marrow-mesenchymal stromal cells either in vitro or in vivo of aplastic anemia mouse model. [Cell Death & Disease] |
|
|
|
| A nude mouse model of subcutaneous xenograft tumor was constructed to detect the effect of miR-139-5p in bone marrow mesenchymal stem cells-derived extracellular vesicles on the tumorigenesis and lung metastasis of bladder cancer cells in vivo. [Cell Death & Disease] |
|
|
|
| Investigators compared graft versus host disease (GVHD) and immune reconstitution after myeloablative matched unrelated peripheral blood stem cell allogeneic stem cell transplant between 30 mg/Kg and 60 mg/Kg anti-lymphocyte globulin. [Bone Marrow Transplantation] |
|
|
|
| The authors explored the impact of post-transplantation cyclophosphamide (PTCy) on human CD8+ T-cell survival and reconstitution, including what cellular pathways drive PTCy resistance. [Blood Advances] |
|
|
|
| Researchers established an immunodeficient murine model of mucopolysaccharidosis type II, which are transplantable human cells, and demonstrated the application of those mice in evaluating the therapeutic efficacy of gene-modified hCD34+ cells. [Gene Therapy] |
|
|
|
| Investigators explored the specificity and safety profile of a new T cell receptor (TCR) mimic-based T cell therapy for hepatocellular carcinoma, a solid tumor for which no effective treatment exists. [Scientific Reports] |
|
|
|
| Scientists assessed the effects of mesenchymal stem cell treatments using a murine model of chronic ovalbumin-challenged asthma. [Scientific Reports] |
| |
|
|
|
| The authors summarize the current understanding of bone remodeling and future research directions with the aim of providing a clinically relevant biological background with which to identify targets for therapeutic strategies in osteoporosis. [Bone Research] |
|
|
|
| To address the unmet need for treatment modalities with increased effectiveness, immune-based therapies such as immune-checkpoint blockade, human papilloma virus-directed vaccines and adoptive T cell therapies have emerged as potential treatment options for advanced penile cancer. [Nature Reviews Urology] |
|
|
|
| Scientists outline the basic structure and characteristics of CAR-T cells among different period, and summarize the common tumor-associated antigens in clinical trials of CAR-T cell therapy for thoracic malignancies. [Frontiers in Immunology] |
|
|
|
|
| Dr. Nathan Singh has received a Damon Runyon Clinical Investigator Award for his research on understanding why CAR-T cell therapy is effective in some patients but not others. [Washington University School of Medicine] |
|
|
|
|
| October 3 – 5, 2022 Vancouver, British Columbia, Canada |
|
|
|
|
|
| St. Jude Children’s Research Hospital – Memphis, Tennessee, United States |
|
|
|
| Lehigh University – Bethlehem, Pennsylvania, Untied States |
|
|
|
| German Cancer Research Center in the Helmholtz Association – Heidelberg, Germany |
|
|
|
| Fred Hutchinson Cancer Research Center – Seattle, Washington, United States |
|
|
|
| University Medical Center Utrecht – Utrecht, Netherlands |
|
|
|
|